Market Update

Life Sciences Software – 2022

January 13, 2022. MPG actively tracks the life sciences software landscape and has been instrumental in strategic deals across the drug development & commercialization spectrum. We’ve noticed a number of recent trends and developments:

  • Life sciences and medical device manufacturers continue to rapidly digitize operations and compliance functions, leading to large scale adoption of quality management software systems
  • Interest in commercialization services is reaching fever pitch as pharma/med device aggressively expand new therapies pipelines amidst rising demand through the pandemic
  • Emphasis on robust patient/physician and trial data assets and insights-based decision making is driving M&A and investment activity across pre-market and post-market analytics vendors
  • Aggressive financial sponsor interest in the life sciences software and services, with multiple tier-one software private equity firms recently placing bets on platforms

Practice Leaders


Rohan Khanna
Managing Director
Jonathan Adler
Managing Director

Get in touch with us

Contact Us

  • Hidden
  • This field is for validation purposes and should be left unchanged.